Genocea Biosciences, Inc. Made Big Gain

Mon, Apr 11, 2022 at 05:30 PM
Genocea Biosciences, Inc. Made Big Gain

Genocea Biosciences, Inc. (GNCA:NASDAQ) rocketted at $0.6, a gain of 50%. On Fri, Apr 08, 2022, GNCA:NASDAQ touched a New 2-Week Low of $0.4. The stock got featured on our News Catalysts scanner on Fri, Apr 08, 2022 at 08:43 PM in the 'BIOTECH' category. From Fri, Mar 25, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days

About Genocea Biosciences, Inc. (GNCA:NASDAQ)

Genocea Biosciences Inc is a biopharmaceutical company that discovers and develops novel vaccines and immunotherapies to address diseases with unmet needs. The Company's products include GEN-003 and GEN-004.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.